Optomed PLC (HE:OPTOMED) — Market Cap & Net Worth
Market Cap & Net Worth: Optomed PLC (OPTOMED)
Optomed PLC (HE:OPTOMED) has a market capitalization of $37.07 Million (€31.71 Million) as of August 1, 2026. Listed on the HE stock exchange, this Finland-based company holds position #22951 globally and #118 in its home market, demonstrating a 2.28% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Optomed PLC's stock price €1.61 by its total outstanding shares 19671255 (19.67 Million). See OPTOMED capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Optomed PLC Market Cap History: 2019 to 2026
Optomed PLC's market capitalization history from 2019 to 2026. Data shows change from $145.81 Million to $37.07 Million (-14.52% CAGR).
Optomed PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Optomed PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
7.13x
Optomed PLC's market cap is 7.13 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $145.81 Million | $14.98 Million | -$2.88 Million | 9.74x | N/A |
| 2020 | $166.04 Million | $13.01 Million | -$3.18 Million | 12.76x | N/A |
| 2021 | $225.38 Million | $14.85 Million | -$4.25 Million | 15.18x | N/A |
| 2022 | $86.13 Million | $14.66 Million | -$5.47 Million | 5.87x | N/A |
| 2023 | $84.52 Million | $15.10 Million | -$4.44 Million | 5.60x | N/A |
| 2024 | $107.17 Million | $15.04 Million | -$5.45 Million | 7.13x | N/A |
Competitor Companies of OPTOMED by Market Capitalization
Companies near Optomed PLC in the global market cap rankings as of August 1, 2026.
Key companies related to Optomed PLC by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #980 globally with a market cap of $27.24 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1931 globally with a market cap of $11.99 Billion USD ( AU$16.95 Billion AUD).
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2123 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2675 globally with a market cap of $7.62 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #980 | Veeva Systems Inc Class A | NYSE:VEEV | $27.24 Billion | $203.78 |
| #1931 | Pro Medicus Ltd | AU:PME | $11.99 Billion | AU$162.21 |
| #2123 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $59.71 |
| #2675 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $7.62 Billion | $43.87 |
Optomed PLC Historical Marketcap From 2019 to 2026
Between 2019 and today, Optomed PLC's market cap moved from $145.81 Million to $ 37.07 Million, with a yearly change of -14.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €37.07 Million | -57.24% |
| 2025 | €86.70 Million | -19.10% |
| 2024 | €107.17 Million | +26.80% |
| 2023 | €84.52 Million | -1.87% |
| 2022 | €86.13 Million | -61.79% |
| 2021 | €225.38 Million | +35.73% |
| 2020 | €166.04 Million | +13.88% |
| 2019 | €145.81 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Optomed PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $37.07 Million USD |
| MoneyControl | $37.07 Million USD |
| MarketWatch | $37.07 Million USD |
| marketcap.company | $37.07 Million USD |
| Reuters | $37.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Optomed PLC
Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consultin… Read more